1,1-dichloroethene decreases expression ISO RGD:1550962 6480464 vinylidene chloride results in decreased expression of CYP2J9 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1550962 6480464 ethylene dichloride results in decreased expression of CYP2J9 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of CYP2J4 mRNA CTD PMID:32387197 1,2-dimethylhydrazine decreases expression ISO RGD:1550962 6480464 1, 2-Dimethylhydrazine results in decreased expression of CYP2J9 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1550962 6480464 Ethinyl Estradiol affects the expression of CYP2J9 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1354467 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP2J2 mRNA CTD PMID:19619570 17beta-estradiol increases expression ISO RGD:1354467 6480464 Estradiol results in increased expression of CYP2J2 mRNA CTD PMID:19619570 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1354467 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP2J2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2J4 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550962 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2J9 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1354467 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2J2 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550962 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2J9 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550962 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2J9 mRNA CTD PMID:16960034 , PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2J4 mRNA, Tetrachlorodibenzodioxin results in decreased expression of CYP2J9 mRNA CTD PMID:16984957 more ... 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CYP2J9 mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases expression ISO RGD:1354467 6480464 Butylated Hydroxytoluene results in increased expression of CYP2J2 mRNA CTD PMID:24021950 2,6-dinitrotoluene affects expression EXP 6480464 2 more ... CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP2J4 mRNA CTD PMID:23358152 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CYP2J4 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression ISO RGD:1550962 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CYP2J9 mRNA CTD PMID:33297965 4-hydroxynon-2-enal multiple interactions ISO RGD:1354467 6480464 [CYP2J2 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid more ... CTD PMID:21766881 5-Hydroxythalidomide increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of 5-hydroxythalidomide CTD PMID:24350712 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CYP2J4 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CYP2J4 mRNA CTD PMID:19483382 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP2J4 mRNA CTD PMID:31881176 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of CYP2J4 mRNA CTD PMID:28959563 Actein decreases expression EXP 6480464 actein results in decreased expression of CYP2J9 protein CTD PMID:29969672 aflatoxin B1 increases response to substance ISO RGD:1354467 6480464 CYP2J2 mRNA results in increased susceptibility to Aflatoxin B1 CTD PMID:29555536 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP2J4 mRNA CTD PMID:33354967 all-trans-retinoic acid decreases expression ISO RGD:1354467 6480464 Tretinoin results in decreased expression of CYP2J2 mRNA CTD PMID:16985168 , PMID:23724009 alpha-naphthoflavone decreases activity ISO RGD:1354467 6480464 alpha-naphthoflavone results in decreased activity of CYP2J2 protein CTD PMID:12851038 amiodarone increases expression ISO RGD:1354467 6480464 Amiodarone results in increased expression of CYP2J2 mRNA CTD PMID:19774075 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CYP2J4 mRNA CTD PMID:19483382 amlodipine decreases activity ISO RGD:1354467 6480464 Amlodipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP2J4 mRNA CTD PMID:16483693 anandamide increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of anandamide CTD PMID:29689453 anandamide multiple interactions ISO RGD:1354467 6480464 cannabichromene inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] more ... CTD PMID:29689453 arachidonic acid multiple interactions ISO RGD:1354467 6480464 Arachidonic Acid inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole] CTD PMID:12386130 arsenous acid decreases response to substance ISO RGD:1354467 6480464 CYP2J2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 astemizole multiple interactions ISO RGD:1354467 6480464 Arachidonic Acid inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole], ebastine inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole] CTD PMID:12386130 astemizole increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of Astemizole CTD PMID:17162467 astemizole decreases methylation ISO RGD:1354467 6480464 CYP2J2 protein results in decreased methylation of Astemizole CTD PMID:12386130 , PMID:15861034 atrazine increases expression ISO RGD:1354467 6480464 Atrazine results in increased expression of CYP2J2 mRNA CTD PMID:22378314 Azelnidipine multiple interactions ISO RGD:1354467 6480464 NADP promotes the reaction [azelnidipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 Azelnidipine decreases activity ISO RGD:1354467 6480464 azelnidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 barnidipine decreases activity ISO RGD:1354467 6480464 mepirodipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 benidipine decreases activity ISO RGD:1354467 6480464 benidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of CYP2J4 mRNA CTD PMID:19483382 benzo[a]pyrene increases expression ISO RGD:1354467 6480464 Benzo(a)pyrene results in increased expression of CYP2J2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression ISO RGD:1354467 6480464 Benzo(a)pyrene results in decreased expression of CYP2J2 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1550962 6480464 Benzo(a)pyrene results in increased methylation of CYP2J9 exon, Benzo(a)pyrene results in increased methylation of CYP2J9 intron CTD PMID:27901495 beta-naphthoflavone decreases expression ISO RGD:1354467 6480464 beta-Naphthoflavone results in decreased expression of CYP2J2 mRNA CTD PMID:32858204 bezafibrate affects expression ISO RGD:1354467 6480464 Bezafibrate affects the expression of CYP2J2 protein CTD PMID:29960002 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1354467 6480464 Diethylhexyl Phthalate results in decreased expression of CYP2J2 mRNA CTD PMID:28412506 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2J2 mRNA more ... CTD PMID:25181051 more ... bisphenol A decreases methylation ISO RGD:1354467 6480464 bisphenol A results in decreased methylation of CYP2J2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1550962 6480464 bisphenol A results in decreased expression of CYP2J9 mRNA CTD PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP2J4 mRNA CTD PMID:33296240 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP2J4 mRNA CTD PMID:30903817 butanal increases expression ISO RGD:1354467 6480464 butyraldehyde results in increased expression of CYP2J2 mRNA CTD PMID:26079696 butylated hydroxyanisole increases expression ISO RGD:1354467 6480464 Butylated Hydroxyanisole results in increased expression of CYP2J2 mRNA CTD PMID:24021950 Cannabichromene increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of cannabichromene CTD PMID:29689453 Cannabichromene multiple interactions ISO RGD:1354467 6480464 cannabichromene inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 cannabidiol multiple interactions ISO RGD:1354467 6480464 Cannabidiol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 cannabidiol increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of Cannabidiol CTD PMID:29689453 cannabigerol increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of cannabigerol CTD PMID:29689453 cannabigerol multiple interactions ISO RGD:1354467 6480464 cannabigerol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 Cannabinol multiple interactions ISO RGD:1354467 6480464 Cannabinol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 Cannabinol increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of Cannabinol CTD PMID:29689453 carbon nanotube decreases expression ISO RGD:1550962 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 ciguatoxin CTX1B affects expression ISO RGD:1550962 6480464 Ciguatoxins affects the expression of CYP2J9 mRNA CTD PMID:18353800 cilnidipine decreases activity ISO RGD:1354467 6480464 cilnidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 cimetidine multiple interactions ISO RGD:1550962 6480464 Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] CTD PMID:11856816 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CYP2J4 mRNA CTD PMID:19483382 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP2J4 mRNA CTD PMID:12851107 clozapine increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of Clozapine CTD PMID:18809730 cocaine increases expression ISO RGD:1550962 6480464 Cocaine results in increased expression of CYP2J2 protein CTD PMID:11856816 cocaine multiple interactions ISO RGD:1550962 6480464 Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein], Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] CTD PMID:11856816 copper(II) sulfate decreases expression ISO RGD:1354467 6480464 Copper Sulfate results in decreased expression of CYP2J2 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1354467 6480464 Cyclosporine results in decreased expression of CYP2J2 mRNA CTD PMID:20106945 , PMID:25562108 danazol decreases activity ISO RGD:1354467 6480464 Danazol results in decreased activity of CYP2J2 protein CTD PMID:29689254 , PMID:30965050 Delapril hydrochloride decreases activity ISO RGD:1354467 6480464 delapril results in decreased activity of CYP2J2 protein CTD PMID:30965050 delta8-THC increases metabolic processing ISO RGD:1354467 6480464 CYP2J2 protein results in increased metabolism of delta-8-tetrahydrocannabinol CTD PMID:29689453 delta8-THC multiple interactions ISO RGD:1354467 6480464 delta-8-tetrahydrocannabinol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 dextran sulfate multiple interactions ISO RGD:1550962 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J9 mRNA CTD PMID:29950665 diarsenic trioxide decreases response to substance ISO RGD:1354467 6480464 CYP2J2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diethyl malate affects expression ISO RGD:1550962 6480464 diethyl malate affects the expression of CYP2J9 mRNA CTD PMID:24814887 doxorubicin multiple interactions ISO RGD:1550962 6480464 CYP2J2 protein affects the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19429816 doxorubicin decreases expression ISO RGD:1354467 6480464 Doxorubicin results in decreased expression of CYP2J2 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:1550962 6480464 Doxorubicin results in decreased expression of CYP2J2 protein CTD PMID:19429816 Ebastine increases hydroxylation ISO RGD:1354467 6480464 CYP2J2 protein results in increased hydroxylation of ebastine CTD PMID:12386130 more ... Ebastine multiple interactions ISO RGD:1354467 6480464 ebastine inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole] CTD PMID:12386130 Ebastine decreases activity ISO RGD:1354467 6480464 ebastine results in decreased activity of CYP2J2 protein CTD PMID:12851038 efonidipine hydrochloride decreases activity ISO RGD:1354467 6480464 efonidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CYP2J4 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1550962 6480464 epoxiconazole results in decreased expression of CYP2J9 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:1550962 6480464 Ethanol results in increased expression of CYP2J9 mRNA CTD PMID:30319688 felodipine multiple interactions ISO RGD:1354467 6480464 NADP promotes the reaction [Felodipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 felodipine decreases activity ISO RGD:1354467 6480464 Felodipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 fenofibrate affects expression ISO RGD:1354467 6480464 Fenofibrate affects the expression of CYP2J2 protein CTD PMID:29960002 fluconazole decreases expression ISO RGD:1550962 6480464 Fluconazole results in decreased expression of CYP2J9 mRNA CTD PMID:16730040 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP2J4 mRNA CTD PMID:24793618 gemfibrozil affects expression ISO RGD:1354467 6480464 Gemfibrozil affects the expression of CYP2J2 protein CTD PMID:29960002 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP2J4 mRNA CTD PMID:24136188 glutathione multiple interactions ISO RGD:1354467 6480464 [CYP2J2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac CTD PMID:24246759 graphite affects expression EXP 6480464 Graphite affects the expression of CYP2J4 mRNA CTD PMID:29933104 ketoconazole decreases activity ISO RGD:1354467 6480464 Ketoconazole results in decreased activity of CYP2J2 protein CTD PMID:12851038 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of CYP2J4 mRNA CTD PMID:19483382 manidipine decreases activity ISO RGD:1354467 6480464 manidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 menadione affects expression ISO RGD:1550962 6480464 Vitamin K 3 affects the expression of CYP2J9 mRNA CTD PMID:20829426 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP2J4 mRNA CTD PMID:23358152 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYP2J4 mRNA CTD PMID:30467583 methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate decreases activity ISO RGD:1354467 6480464 Nisoldipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 metyrapone multiple interactions ISO RGD:1550962 6480464 Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] CTD PMID:11856816 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP2J4 mRNA CTD PMID:21515302 N-desmethylclozapine increases chemical synthesis ISO RGD:1354467 6480464 CYP2J2 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of CYP2J9 mRNA CTD PMID:17412507 NADP zwitterion multiple interactions ISO RGD:1354467 6480464 NADP promotes the reaction [azelnidipine results in decreased activity of CYP2J2 protein], NADP promotes the reaction [Felodipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 NADP(+) multiple interactions ISO RGD:1354467 6480464 NADP promotes the reaction [azelnidipine results in decreased activity of CYP2J2 protein], NADP promotes the reaction [Felodipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 nicardipine decreases activity ISO RGD:1354467 6480464 Nicardipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 nifedipine decreases activity ISO RGD:1354467 6480464 Nifedipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Nilvadipine decreases activity ISO RGD:1354467 6480464 nilvadipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 nisoldipine decreases activity ISO RGD:1354467 6480464 Nisoldipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 nitrendipine decreases activity ISO RGD:1354467 6480464 Nitrendipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of CYP2J4 mRNA CTD PMID:18417182 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CYP2J4 mRNA CTD PMID:19483382 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of CYP2J4 mRNA CTD PMID:23439660 ozone multiple interactions ISO RGD:1550962 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP2J9 mRNA CTD PMID:34911549 paclitaxel multiple interactions ISO RGD:1550962 6480464 [rottlerin co-treated with Paclitaxel] results in decreased expression of CYP2J2 protein CTD PMID:35995259 paracetamol affects expression ISO RGD:1550962 6480464 Acetaminophen affects the expression of CYP2J9 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1354467 6480464 Acetaminophen results in decreased expression of CYP2J2 mRNA CTD PMID:29067470 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP2J9 mRNA CTD PMID:17366322 paraquat increases expression ISO RGD:1550962 6480464 Paraquat results in increased expression of CYP2J9 mRNA CTD PMID:21371552 pentanal increases expression ISO RGD:1354467 6480464 pentanal results in increased expression of CYP2J2 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2J4 mRNA CTD PMID:18692542 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2J4 mRNA CTD PMID:16221955 , PMID:28511854 perfluorooctanoic acid increases expression ISO RGD:1354467 6480464 perfluorooctanoic acid results in increased expression of CYP2J2 mRNA CTD PMID:32588087 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CYP2J4 mRNA CTD PMID:22484513 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CYP2J4 mRNA CTD PMID:19483382 pirinixic acid affects expression ISO RGD:1354467 6480464 pirinixic acid affects the expression of CYP2J2 protein CTD PMID:29960002 pirinixic acid multiple interactions ISO RGD:1354467 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP2J2 mRNA CTD PMID:19710929 pomalidomide increases oxidation ISO RGD:1354467 6480464 CYP2J2 protein results in increased oxidation of pomalidomide CTD PMID:24350712 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of CYP2J4 mRNA CTD PMID:27225895 prochloraz decreases expression ISO RGD:1354467 6480464 prochloraz results in decreased expression of CYP2J2 mRNA CTD PMID:20035023 propanal increases expression ISO RGD:1354467 6480464 propionaldehyde results in increased expression of CYP2J2 mRNA CTD PMID:26079696 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP2J9 mRNA CTD PMID:16643972 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP2J4 mRNA CTD PMID:23358152 quercetin increases expression ISO RGD:1354467 6480464 Quercetin results in increased expression of CYP2J2 mRNA CTD PMID:21632981 quercetin decreases expression ISO RGD:1550962 6480464 Quercetin results in decreased expression of CYP2J2 mRNA CTD PMID:16455785 quinapril hydrochloride decreases activity ISO RGD:1354467 6480464 Quinapril results in decreased activity of CYP2J2 protein CTD PMID:30965050 rifampicin decreases expression ISO RGD:1354467 6480464 Rifampin results in decreased expression of CYP2J2 mRNA CTD PMID:33263786 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP2J4 mRNA CTD PMID:28374803 rottlerin multiple interactions ISO RGD:1550962 6480464 [rottlerin co-treated with Paclitaxel] results in decreased expression of CYP2J2 protein CTD PMID:35995259 Salvianolic acid A decreases activity ISO RGD:1354467 6480464 salvianolic acid A results in decreased activity of CYP2J2 protein CTD PMID:29689254 Salvianolic acid C decreases activity ISO RGD:1354467 6480464 salvianolic acid C results in decreased activity of CYP2J2 protein CTD PMID:29689254 sodium arsenite increases expression ISO RGD:1354467 6480464 sodium arsenite results in increased expression of CYP2J2 mRNA CTD PMID:21281968 sodium arsenite decreases expression ISO RGD:1354467 6480464 sodium arsenite results in decreased expression of CYP2J2 mRNA CTD PMID:29301061 , PMID:34032870 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYP2J4 mRNA CTD PMID:25905778 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP2J4 mRNA CTD PMID:20371263 telmisartan decreases activity ISO RGD:1354467 6480464 Telmisartan results in decreased activity of CYP2J2 protein CTD PMID:30965050 Terfenadine increases hydroxylation ISO RGD:1354467 6480464 CYP2J2 protein results in increased hydroxylation of Terfenadine CTD PMID:24021950 Terfenadine decreases activity ISO RGD:1354467 6480464 Terfenadine analog results in decreased activity of CYP2J2 protein, Terfenadine results in decreased activity of CYP2J2 protein CTD PMID:12851038 , PMID:19289568 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP2J4 mRNA CTD PMID:21515302 tetrachloromethane decreases expression ISO RGD:1550962 6480464 Carbon Tetrachloride results in decreased expression of CYP2J9 mRNA CTD PMID:27339419 , PMID:31919559 tetracycline increases expression ISO RGD:1550962 6480464 Tetracycline results in increased expression of CYP2J9 mRNA CTD PMID:16917069 tetraphene decreases expression ISO RGD:1550962 6480464 benz(a)anthracene results in decreased expression of CYP2J9 mRNA CTD PMID:26377693 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CYP2J4 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP2J4 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:1550962 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J9 mRNA CTD PMID:29950665 tranylcypromine decreases activity ISO RGD:1354467 6480464 Tranylcypromine results in decreased activity of CYP2J2 protein CTD PMID:12851038 triadimefon increases expression ISO RGD:1550962 6480464 triadimefon results in increased expression of CYP2J9 mRNA CTD PMID:16730040 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP2J9 mRNA CTD PMID:16643972 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP2J4 mRNA CTD PMID:33387578 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of CYP2J4 mRNA CTD PMID:30447264 trimellitic anhydride decreases expression ISO RGD:1550962 6480464 trimellitic anhydride results in decreased expression of CYP2J9 mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CYP2J4 mRNA CTD PMID:30589522 troglitazone decreases activity ISO RGD:1354467 6480464 troglitazone results in decreased activity of CYP2J2 protein CTD PMID:12851038 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP2J4 mRNA CTD PMID:21515302 urethane increases expression ISO RGD:1354467 6480464 Urethane results in increased expression of CYP2J2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1550962 6480464 Valproic Acid affects the expression of CYP2J9 mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:1354467 6480464 Valproic Acid results in increased expression of CYP2J2 mRNA CTD PMID:28001369 , PMID:29154799 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP2J4 mRNA CTD PMID:23034163 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP2J4 mRNA CTD PMID:27225895